Two distinct, membrane-bound, FAD-containing enzymes catalyze the interconversion of fumarate and succinate. Fumarate reductase is utilized during anaerobic growth, while succinate dehydrogenase is used during aerobic growth. FrdC anchors the catalytic components of the fumarate reductase complex to the inner cell membrane and binds quinones.
KEGG: sek:SSPA3862
FrdC plays a central role in the sophisticated electron/proton transfer mechanisms required for anaerobic respiration in S. paratyphi A:
Electron Transfer Pathway:
The membrane-embedded frdC subunit contains binding sites for quinones and heme groups that facilitate electron transfer. Research on QFR complexes from anaerobic bacteria reveals that one menaquinone molecule binds near heme bL in the hydrophobic subunit C . This bound menaquinone serves as an additional redox cofactor that mediates the proton-coupled electron transport across the membrane.
Quinol + Fumarate → Quinone + Succinate
This reaction couples electron transfer from quinol to fumarate with proton translocation across the membrane. The structural arrangement of frdC's transmembrane helices creates channels for proton movement during this process .
Spectroscopic and crystallographic studies of homologous QFR complexes suggest that electrons from quinol are transferred through heme groups within frdC to the iron-sulfur clusters in subunit B and ultimately to the FAD cofactor in subunit A, where fumarate reduction occurs.
Research demonstrates that fumarate reductase is a major contributor to reactive oxygen species (ROS) generation in anaerobic bacteria . While most studies have been conducted on related bacteria, the mechanism likely applies to S. paratyphi A:
Mechanism of ROS Generation:
When exposed to oxygen, the fumarate reductase complex, particularly the frdC subunit with its electron-carrying components, can inadvertently transfer electrons to molecular oxygen instead of fumarate. This generates superoxide radicals (O₂⁻), which can be converted to hydrogen peroxide (H₂O₂) and other reactive oxygen species.
Experimental Evidence:
Studies in Bacteroides fragilis showed that:
Deletion of frdC significantly reduced H₂O₂ production
The frdC deletion mutant displayed increased aerotolerance in a superoxide dismutase-deficient background
Exogenous fumarate reduced H₂O₂ production in strains lacking key peroxide-detoxifying enzymes
In S. paratyphi A, this ROS generation may have dual effects:
Contributing to oxidative stress within the bacterium itself
Potentially enhancing tissue damage during infection
Modulating host immune responses through oxidative signaling
Research with C. elegans models confirmed that "S. Paratyphi A could increase oxidative stress and regulate the immune response" , suggesting that ROS generation mechanisms, potentially involving frdC, represent an important aspect of host-pathogen interactions.
Genetic Approaches:
Gene knockout and complementation:
Lambda Red recombination for targeted frdC deletion
Complementation with wild-type frdC in trans to verify phenotypes
Growth analysis under aerobic versus anaerobic conditions
Site-directed mutagenesis:
Targeting conserved residues important for heme binding
Creating mutations that affect quinone binding sites
Altering transmembrane domains to study membrane integration
Biochemical Methods:
Enzyme activity assays:
Membrane vesicle preparation for in vitro fumarate reductase activity
Measuring quinol oxidation and fumarate reduction rates
Kinetic analysis with various substrates and inhibitors
Protein-protein interaction studies:
Co-immunoprecipitation with other QFR subunits
Bacterial two-hybrid systems
Cross-linking experiments followed by mass spectrometry
Structural Analysis:
X-ray crystallography or cryo-electron microscopy
Hydrogen-deuterium exchange mass spectrometry
EPR spectroscopy to study heme environments
Cell Culture Models:
Following techniques described in source :
HeLa and Caco-2 epithelial cell infection models (MOI 1:50)
RAW264.7 macrophage infection (MOI 1:10)
Gentamicin protection assays for intracellular survival quantification
Comparing wild-type and frdC mutant strains for invasion and persistence
Animal Models:
Mouse models of infection to assess virulence of frdC mutants
Omics Approaches:
RNA-seq to identify transcriptional changes in frdC mutants
Proteomics to detect altered protein expression patterns
Metabolomics to identify metabolic shifts in the absence of frdC
The contribution of frdC to S. paratyphi A pathogenesis involves several interconnected mechanisms:
Adaptation to Host Environments:
During infection, S. paratyphi A encounters various microenvironments with limited oxygen, particularly within macrophages and in intestinal tissues. The QFR complex containing frdC enables anaerobic respiration, providing a metabolic advantage for survival and replication in these niches .
Infection Process:
The pathogenesis of S. paratyphi A infection follows a specific trajectory where metabolic adaptation is critical:
Ingestion through contaminated food/water
Survival in the acidic stomach environment
Invasion of intestinal epithelial cells, especially M cells
Dissemination to mesenteric lymph nodes and bloodstream
FrdC-containing fumarate reductase likely supports bacterial metabolism during these stages, particularly during intracellular survival.
ROS-Mediated Tissue Damage:
The generation of reactive oxygen species by fumarate reductase may contribute to host tissue damage, potentially enhancing bacterial dissemination. Studies indicate that S. paratyphi A increases oxidative stress in infection models , which may be partially attributed to frdC activity.
Metabolic Signature:
Metabolomic studies have identified distinct metabolite profiles in patients with S. paratyphi A infections . These profiles reflect the unique metabolism of this pathogen, potentially influenced by anaerobic respiratory enzymes like the QFR complex.
Genome Structure Considerations:
The genome of S. paratyphi A contains unique rearrangements, including an inversion of half the genome between rrnH and rrnG and a 100-kb insertion between rrnH/G and proB . These genomic features may influence the expression and function of respiratory enzymes, including the frdC-containing QFR complex.
FrdC represents a promising antimicrobial target due to its essential role in anaerobic metabolism and potential contribution to virulence:
Target Validation Approaches:
Genetic validation:
Creating conditional frdC mutants to confirm essentiality
Determining growth inhibition under various conditions
Assessing attenuation of virulence in frdC mutants
Chemical validation:
Testing known fumarate reductase inhibitors
Structure-activity relationship studies
Target engagement assays in whole cells
Drug Development Strategies:
Structure-based drug design:
Utilizing structural information about frdC and the QFR complex
Rational design of inhibitors targeting quinol binding sites
Computer-aided drug design approaches
High-throughput screening:
Development of cell-based or enzyme-based assays
Screening chemical libraries for inhibition of fumarate reductase activity
Counter-screens against human enzymes to ensure selectivity
Antimicrobial Mechanisms:
Direct inhibition of enzyme activity
Disruption of protein-protein interactions within the QFR complex
Prevention of heme incorporation
Interference with membrane integration
Addressing Antimicrobial Resistance:
With increasing antimicrobial resistance in S. paratyphi A , targeting metabolic pathways such as anaerobic respiration provides a novel approach that could circumvent existing resistance mechanisms. The genomic analysis reveals that while antimicrobial resistance genes are relatively rare in S. paratyphi A (only 2% of 1379 genomes analyzed contained resistance genes), mutations in the quinolone resistance-determining region (QRDR) are common (85% of genomes) , highlighting the need for new antibiotic targets.
While current S. paratyphi A vaccine development has focused primarily on other antigenic targets, frdC represents a potential component for novel vaccine strategies:
Subunit Vaccine Approach:
Recombinant frdC could be formulated as a subunit vaccine component, similar to other membrane proteins of S. paratyphi A that have shown immunogenic potential. Research has demonstrated that several outer membrane proteins (LamB, PagC, TolC, NmpC, and FadL) conferred significant immunoprotection in mice with protection rates of 95%, 95%, 85%, 80%, and 70%, respectively .
Evaluation Process:
Immunogenicity assessment:
Animal immunization with purified recombinant frdC
Measurement of antibody titers and specificity
Assessment of T-cell responses
Protection studies:
Challenge experiments in appropriate animal models
Determination of bacterial loads in tissues
Survival analysis
Adjuvant Selection:
The hydrophobic nature of frdC would require careful adjuvant selection and formulation strategies to enhance immunogenicity and ensure proper protein presentation to the immune system.
Combination Approaches:
Given the progress with O-antigen conjugate vaccines for S. paratyphi A , frdC could potentially be incorporated into multicomponent vaccines combining:
O:2-CRM197 conjugates
Multiple protein antigens
Live attenuated vaccine platforms
For example, O:2-CRM197 conjugates have shown strong serum bactericidal activity against S. paratyphi A in mouse models, with immunized mice developing high levels of anti-OSP IgG with bactericidal properties . A similar approach could be explored with frdC, potentially as part of a broader antigen repertoire.
Genomic analysis of frdC across Salmonella strains provides valuable evolutionary insights:
Genomic Context:
The genome of S. paratyphi A features unique structural characteristics that may influence frdC expression and function:
An inversion of half the genome between rrnH and rrnG
A 100-kb insertion between rrnH/G and proB
These rearrangements are present in all wild-type S. paratyphi A strains tested
Evolutionary Conservation:
Genomic surveillance tools like Paratype have enabled comprehensive analysis of S. paratyphi A genomes, revealing population structure and evolutionary relationships . Analysis of 1379 S. paratyphi A genomes identified:
Three primary clades
Nine secondary clades
18 distinct genotypes
While frdC-specific analysis is not directly mentioned, the conservation of essential metabolic genes across these genotypes would provide insights into selection pressures and functional constraints on respiratory proteins.
Comparative Analysis:
Comparing frdC sequences across:
Different Salmonella serovars
Isolates from different geographical regions
Clinical versus environmental isolates
Antimicrobial resistant versus susceptible strains
Such analysis could reveal correlations between frdC sequence variations and:
Virulence potential
Host adaptation
Metabolic capabilities
Geographic distribution